An impurity of Eptifibatide. Eptifibatide, is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the so-called RGD (arginine-glycine-aspartate)-mimetics and reversibly binds to platelets.
CAT No: 10-101-202
Eptifibatide Impurity 2 is a specialized carbohydrate compound often encountered as a process-related substance during the synthesis and quality assessment of eptifibatide, a cyclic heptapeptide. This impurity arises due to variations in the synthetic route or as a byproduct during peptide modification steps. Its unique structural attributes make it a critical analytical reference in pharmaceutical research and peptide chemistry. Researchers value Eptifibatide Impurity 2 for its role in ensuring the integrity and safety of the final peptide product, as its presence can indicate process efficiency, potential degradation pathways, and the overall robustness of peptide synthesis protocols. The compound's detailed characterization supports a deeper understanding of peptide-related impurities and their impact on the biological and physicochemical properties of therapeutic candidates.
Pharmaceutical Research: Within pharmaceutical development, Eptifibatide Impurity 2 serves as an essential analytical standard for method validation and impurity profiling. Scientists incorporate this compound into high-performance liquid chromatography (HPLC) and mass spectrometry workflows to accurately detect, quantify, and monitor trace levels of impurities during active pharmaceutical ingredient (API) synthesis. By comparing the retention time and spectral data of the impurity to reference standards, researchers can optimize purification procedures and refine synthetic routes, ultimately improving the overall yield and quality of the target peptide. The availability of this impurity as a reference material enhances the reliability of impurity identification and quantitation, which is crucial for comprehensive risk assessment in drug development pipelines.
Peptide Synthesis Optimization: In the field of peptide chemistry, Eptifibatide Impurity 2 is used to investigate the efficiency of various coupling reagents, protecting group strategies, and cyclization conditions. By monitoring the formation and persistence of this impurity under different synthetic conditions, chemists can gain insights into potential side reactions and degradation mechanisms. This information is invaluable for troubleshooting synthesis issues, minimizing byproduct formation, and achieving higher purity levels in the final peptide product. Furthermore, the study of such impurities contributes to the design of more robust and scalable manufacturing processes, reducing production costs and enhancing reproducibility.
Analytical Method Development: Analytical laboratories utilize Eptifibatide Impurity 2 to develop, validate, and calibrate advanced detection methods for peptide impurities. Its well-defined chemical structure allows for precise calibration of analytical instruments, ensuring accurate quantification in complex peptide mixtures. The impurity is frequently employed in forced degradation studies, where its behavior under stress conditions such as heat, light, or pH extremes is closely monitored. These studies assist in establishing degradation pathways and setting appropriate storage and handling protocols for peptide therapeutics.
Structure-Activity Relationship Studies: The presence of Eptifibatide Impurity 2 provides a valuable tool for structure-activity relationship (SAR) investigations. By comparing the biological or physicochemical properties of the impurity with those of the parent peptide, researchers can elucidate the impact of specific structural modifications on molecular activity, stability, and solubility. Such comparative studies advance our understanding of peptide design principles and inform the development of next-generation peptide therapeutics with improved efficacy and safety profiles.
Quality Control and Assurance: In manufacturing environments, Eptifibatide Impurity 2 is integrated into routine quality control assays to verify the consistency and purity of peptide batches. Its detection at defined levels ensures that process deviations or contamination events are promptly identified and addressed. By serving as a benchmark for impurity monitoring, the compound supports the implementation of robust quality assurance protocols, reducing the risk of product recalls and enhancing consumer confidence in peptide-based products. The application of this impurity in quality control workflows underscores its significance in maintaining high manufacturing standards and ensuring the long-term success of peptide therapeutics in the market.
2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
3. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More